Follow the Medicamen Biotech Limited share price and the full directors' dealings record of the company, a listed issuer based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Medicamen Biotech Limited has recorded 30 reports. Market capitalisation: €3.9bn. The latest transaction was filed on 24 September 2025 (Sale). Among the most active insiders: Geetika Madan. The full history is openly available.
30
Insider Decl.
0
Thresholds
€1m
7 ops.
Buy Volume
€3m
23 ops.
Sell Volume
10Σ signal
Buys €1m€3m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,104 of 26,211 companies
41.9
score / 100
Value
32
Quality
52
FCF yld-11%
Earn yld2.9%
EV/EBITDA16.8x
ROE4.0%
Gross mgn49%
Net mgn4.9%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.